The prevalence of antimicrobial resistance in clinical isolates from Gulf Corporation Council countries

Antimicrobial Resistance and Infection Control

Mahmoud Aly²  Hanan H Balkhy¹ 

[1] King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia

[2] King Abdullah International Medical Research Center, Riyadh, Saudi Arabia

关键词: Molecular typing;    Resistance mechanisms;    Infection;    Pathogens;    Anaerobes;    Gram positive;    (Saudi Arabia, Qatar, Bahrain, Kuwait, Oman, and United Arab Emirates) Gram negative;    GCC;    Resistance;    Antibiotics/antimicrobials;   

Others  :  791164
DOI  :  10.1186/2047-2994-1-26

 received in 2012-03-28, accepted in 2012-07-19,  发布年份 2012

【 摘 要 】

Background

The burden of antimicrobial resistance worldwide is substantial and is likely to grow. Many factors play a role in the emergence of resistance. These resistance mechanisms may be encoded on transferable genes, which facilitate the spread of resistance between bacterial strains of the same and/or different species. Other resistance mechanisms may be due to alterations in the chromosomal DNA which enables the bacteria to withstand the environment and multiply. Many, if not most, of the Gulf Corporation Council (GCC) countries do not have clear guidelines for antimicrobial use, and lack policies for restricting and auditing antimicrobial prescriptions.

Objective

The aim of this study is to review the prevalence of antibiotic resistance in GCC countries and explore the reasons for antibiotic resistance in the region.

Methodology

The PubMed database was searched using the following key words: antimicrobial resistance, antibiotic stewardship, prevalence, epidemiology, mechanism of resistance, and GCC country (Saudi Arabia, Qatar, Bahrain, Kuwait, Oman, and United Arab Emirates).

Results

From January1990 through April 2011, there were 45 articles published reviewing antibiotic resistance in the GCC countries. Among all the GCC countries, 37,295 bacterial isolates were studied for antimicrobial resistance. The most prevalent microorganism was Escherichia coli (10,073/44%), followed by Klebsiella pneumoniae (4,709/20%), Pseudomonas aeruginosa (4,287/18.7%), MRSA (1,216/5.4%), Acinetobacter (1,061/5%), with C. difficile and Enterococcus representing less than 1%.

Conclusion

In the last 2 decades, E. coli followed by Klebsiella pneumoniae were the most prevalent reported microorganisms by GCC countries with resistance data.

【 授权许可】

   
2012 Aly and Balkhy; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]WHO: World Health Day – 7 April 2011"Antimicrobial resistance: no action today, no cure tomorrow". In Book World Health Day – 7 April 2011"Antimicrobial resistance: no action today, no cure tomorrow" (Editor ed.^eds.). City; 2011.
• [2]Paterson DL, Bonomo RA: Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 2005, 18:657-686.
• [3]Memish ZA, Ahmed QA, Arabi YM, Shibl AM, Niederman MS: Microbiology of community-acquired pneumonia in the Gulf Corporation Council states. J Chemother 2007, 19(Suppl 1):17-23.
• [4]Bindayna KM, Senok AC, Jamsheer AE: Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Bahrain. J Infect Public Health 2009, 2:129-135.
• [5]Udo EE, Panigrahi D, Jamsheer AE: Molecular typing of methicillin-resistant Staphylococcus aureus isolated in a Bahrain hospital. Med Princ Pract 2008, 17:308-314.
• [6]Wallace MR, Johnson AP, Daniel M, Malde M, Yousif AA: Sequential emergence of multi-resistant Klebsiella pneumoniae in Bahrain. J Hosp Infect 1995, 31:247-252.
• [7]Shigidi MM, Fituri OM, Chandy SK, Asim M, Al Malki HA, Rashed AH: Microbial spectrum and outcome of peritoneal dialysis related peritonitis in Qatar. Saudi J Kidney Dis Transpl 2010, 21:168-173.
• [8]Al Benwan K, Al Sweih N, Rotimi VO: Etiology and antibiotic susceptibility patterns of community- and hospital-acquired urinary tract infections in a general hospital in Kuwait. Med Princ Pract 2010, 19:440-446.
• [9]Dashti AA, Jadaon MM, Amyes SG: Retrospective study of an outbreak in a Kuwaiti hospital of multidrug-resistant Klebsiella pneumoniae possessing the new SHV-112 extended-spectrum beta-lactamase. J Chemother 2010, 22:335-338.
• [10]Jamal W, Rotimi VO, Brazier J, Duerden BI: Analysis of prevalence, risk factors and molecular epidemiology of Clostridium difficile infection in Kuwait over a 3-year period. Anaerobe 2010, 16:560-565.
• [11]Jamal WY, El-Din K, Rotimi VO, Chugh TD: An analysis of hospital-acquired bacteraemia in intensive care unit patients in a university hospital in Kuwait. J Hosp Infect 1999, 43:49-56.
• [12]Johny M, Babelly M, Al-Obaid I, Al-Benwan K, Udo EE: Antimicrobial resistance in clinical isolates of Streptococcus pneumoniae in a tertiary hospital in Kuwait, 1997–2007: implications for empiric therapy. J Infect Public Health 2010, 3:60-66.
• [13]Mokaddas EM, Abdulla AA, Shati S, Rotimi VO: The technical aspects and clinical significance of detecting extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary-care hospital in Kuwait. J Chemother 2008, 20:445-451.
• [14]Rotimi VO, Al-Sweih NA, Feteih J: The prevalence and antibiotic susceptibility pattern of gram-negative bacterial isolates in two ICUs in Saudi Arabia and Kuwait. Diagn Microbiol Infect Dis 1998, 30:53-59.
• [15]Rotimi VO, Mokaddas EM, Jamal WY, Verghese TL, El-Din K, Junaid TA: Hospital-acquired Clostridium difficile infection amongst ICU and burn patients in Kuwait. Med Princ Pract 2002, 11:23-28.
• [16]Prasanna M, Thomas C: A profile of methicillin resistant Staphylococcus aureus infection in the burn center of the Sultanate of Oman. Burns 1998, 24:631-636.
• [17]Poirel L, Al Maskari Z, Al Rashdi F, Bernabeu S, Nordmann P: NDM-1-producing Klebsiella pneumoniae isolated in the Sultanate of Oman. J Antimicrob Chemother 2011, 66:304-306.
• [18]Khan FY, Elshafie SS, Almaslamani M, Abu-Khattab M, El Hiday AH, Errayes M, Almaslamani E: Epidemiology of bacteraemia in Hamad general hospital, Qatar: a one year hospital-based study. Travel Med Infect Dis 2010, 8:377-387.
• [19]Ahmad S, Al-Juaid NF, Alenzi FQ, Mattar EH, Bakheet Oel S: Prevalence, antibiotic susceptibility pattern and production of extended-spectrum beta-lactamases amongst clinical isolates of Klebsiella pneumoniae at Armed Forces Hospital in Saudi Arabia. J Coll Physicians Surg Pak 2009, 19:264-265.
• [20]Akhter J, Frayha HH, Qadri SM: Current status and changing trends of antimicrobial resistance in Saudi Arabia. J Med Liban 2000, 48:227-232.
• [21]Al Johani SM, Akhter J, Balkhy H, El-Saed A, Younan M, Memish Z: Prevalence of antimicrobial resistance among gram-negative isolates in an adult intensive care unit at a tertiary care center in Saudi Arabia. Ann Saudi Med 2010, 30:364-369.
• [22]Al-Tawfiq JA, Abed MS: Prevalence and antimicrobial resistance of health care associated bloodstream infections at a general hospital in Saudi Arabia. Saudi Med J 2009, 30:1213-1218.
• [23]Al-Tawfiq JA, Abed MS: Clostridium difficile-associated disease among patients in Dhahran, Saudi Arabia. Travel Med Infect Dis 2010, 8:373-376.
• [24]Al-Tawfiq JA, Antony A: Antimicrobial resistance of Klebsiella pneumoniae in a Saudi Arabian hospital: results of a 6-year surveillance study, 1998–2003. J Infect Chemother 2007, 13:230-234.
• [25]Asghar AH, Faidah HS: Frequency and antimicrobial susceptibility of gram-negative bacteria isolated from 2 hospitals in Makkah, Saudi Arabia. Saudi Med J 2009, 30:1017-1023.
• [26]Babay HA: Antimicrobial resistance among clinical isolates of Pseudomonas aeruginosa from patients in a teaching hospital, Riyadh, Saudi Arabia, 2001–2005. Jpn J Infect Dis 2007, 60:123-125.
• [27]Balkhy HH, Cunningham G, Chew FK, Francis C, Al Nakhli DJ, Almuneef MA, Memish ZA: Hospital- and community-acquired infections: a point prevalence and risk factors survey in a tertiary care center in Saudi Arabia. Int J Infect Dis 2006, 10:326-333.
• [28]Balkhy HH, Memish ZA, Shibl A, Elbashier A, Osoba A: In vitro activity of quinolones against S. pneumoniae, H. influenzae and M. catarrhalis in Saudi Arabia. East Mediterr Health J 2005, 11:36-44.
• [29]Bilal NE, Gedebou M: Staphylococcus aureus as a paradigm of a persistent problem of bacterial multiple antibiotic resistance in Abha, Saudi Arabia. East Mediterr Health J 2000, 6:948-954.
• [30]Fouda SI, Kadry AA, Shibl AM: Beta-lactam and macrolide resistance and serotype distribution among Streptococcus pneumoniae isolates from Saudi Arabia. J Chemother 2004, 16:517-523.
• [31]Memish ZA, Balkhy HH, Shibl AM, Barrozo CP, Gray GC: Streptococcus pneumoniae in Saudi Arabia: antibiotic resistance and serotypes of recent clinical isolates. Int J Antimicrob Agents 2004, 23:32-38.
• [32]Shibl AM, Al Rasheed AM, Elbashier AM, Osoba AO: Penicillin-resistant and -intermediate Streptococcus pneumoniae in Saudi Arabia. J Chemother 2000, 12:134-137.
• [33]Al-Muhairi S, Zoubeidi T, Ellis M, Nicholls MG, Safa W, Joseph J: Demographics and microbiological profile of pneumonia in United Arab Emirates. Monaldi Arch Chest Dis 2006, 65:13-18.
• [34]Al-Zarouni M, Senok A, Rashid F, Al-Jesmi SM, Panigrahi D: Prevalence and antimicrobial susceptibility pattern of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the United Arab Emirates. Med Princ Pract 2008, 17:32-36.
• [35]Aly NY, Al-Mousa HH, Al Asar el SM: Nosocomial infections in a medical-surgical intensive care unit. Med Princ Pract 2008, 17:373-377.
• [36]Babay HA, Twum-Danso K, Kambal AM, Al-Otaibi FE: Bloodstream infections in pediatric patients. Saudi Med J 2005, 26:1555-1561.
• [37]Bang RL, Gang RK, Sanyal SC, Mokaddas E, Ebrahim MK: Burn septicaemia: an analysis of 79 patients. Burns 1998, 24:354-361.
• [38]Bukharie HA, Abdelhadi MS, Saeed IA, Rubaish AM, Larbi EB: Emergence of methicillin-resistant Staphylococcus aureus as a community pathogen. Diagn Microbiol Infect Dis 2001, 40:1-4.
• [39]Gang RK, Bang RL, Sanyal SC, Mokaddas E, Lari AR: Pseudomonas aeruginosa septicaemia in burns. Burns 1999, 25:611-616.
• [40]Jumaa PA, Neringer R: A survey of antimicrobial resistance in a tertiary referral hospital in the United Arab Emirates. J Chemother 2005, 17:376-379.
• [41]Kader AA, Kumar A: Prevalence and antimicrobial susceptibility of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a general hospital. Ann Saudi Med 2005, 25:239-242.
• [42]Narchi H, Al-Hamdan MA: Antibiotic resistance trends in paediatric community-acquired first urinary tract infections in the United Arab Emirates. East Mediterr Health J 2010, 16:45-50.
• [43]Nzeako BC, Al Daughari H, Al Lamki Z, Al Rawas O: Nature of bacteria found on some wards in Sultan Qaboos University Hospital, Oman. Br J Biomed Sci 2006, 63:55-58.
• [44]Shamseldin el Shafie S, Smith W, Donnelly G: An outbreak of gentamicin-resistant Klebsiella pneumoniae in a neonatal ward. Cent Eur J Public Health 1995, 3:129-131.
• [45]Udo EE, Al-Sweih N, Phillips OA, Chugh TD: Species prevalence and antibacterial resistance of enterococci isolated in Kuwait hospitals. J Med Microbiol 2003, 52:163-168.
• [46]Balkhy H, El-Saed A, Al Johani S, Tayeb H, Al-Qahtani A, Alahdal M, Sallah M, Alothman A, Alarabi Y: Epidemiology of the first outbreak of carbapenem-resistant Klebsiella pneumoniae in Saudi Arabia. BMC Proceedings 2011, 5:P295. BioMed Central Full Text